{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:09:45Z","timestamp":1783937385080,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.wneu.2016.05.081","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T19:13:51Z","timestamp":1465067631000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease"],"prefix":"10.1016","volume":"93","author":[{"given":"Faliang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanbing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2016.05.081_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular moyamoya disease: disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch Neurol"},{"key":"10.1016\/j.wneu.2016.05.081_bib2","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","article-title":"RNF213 rare variants in an ethnically diverse population with Moyamoya disease","volume":"45","author":"Cecchi","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2016.05.081_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000352065","article-title":"Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant","volume":"36","author":"Mineharu","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2016.05.081_bib4","first-page":"790","volume":"30","author":"Mathieu","year":"2013","journal-title":"Med Sci M\/S"},{"key":"10.1016\/j.wneu.2016.05.081_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.wneu.2016.05.081_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/path.2638","article-title":"Noncoding RNAs: regulators of disease","volume":"220","author":"Taft","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.wneu.2016.05.081_bib7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/CIRCRESAHA.112.268953","article-title":"Long noncoding RNAs in cardiac development and pathophysiology","volume":"111","author":"Schonrock","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.wneu.2016.05.081_bib8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1210\/en.2009-1151","article-title":"Increased expression of angiogenic genes in the brains of mouse meg3-null embryos","volume":"151","author":"Gordon","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.wneu.2016.05.081_bib9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","article-title":"Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth","volume":"114","author":"Michalik","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.wneu.2016.05.081_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/ATVBAHA.109.196832","article-title":"ANRIL expression is associated with atherosclerosis risk at chromosome 9p21","volume":"30","author":"Holdt","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.wneu.2016.05.081_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2011.11.017","article-title":"Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A\/B","volume":"220","author":"Congrains","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.wneu.2016.05.081_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bbrc.2012.02.050","article-title":"CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC","volume":"419","author":"Congrains","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.wneu.2016.05.081_bib13","doi-asserted-by":"crossref","first-page":"e1003588","DOI":"10.1371\/journal.pgen.1003588","article-title":"Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks","volume":"9","author":"Holdt","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.wneu.2016.05.081_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Hashimoto","year":"2012","journal-title":"Neurol Med Chir"},{"key":"10.1016\/j.wneu.2016.05.081_bib15","doi-asserted-by":"crossref","first-page":"e102382","DOI":"10.1371\/journal.pone.0102382","article-title":"Serum miRNA signature in Moyamoya disease","volume":"9","author":"Dai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2016.05.081_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2152-7806.97730","article-title":"Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in moyamoya disease: a review of the literature","volume":"3","author":"Ryan","year":"2012","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.wneu.2016.05.081_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","article-title":"Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease","volume":"24","author":"Takekawa","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.wneu.2016.05.081_bib18","first-page":"6","article-title":"Moyamoya disease: a review","volume":"50","author":"Gosalakkal","year":"2002","journal-title":"Neurol India"},{"key":"10.1016\/j.wneu.2016.05.081_bib19","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.3171\/2011.3.FOCUS1151","article-title":"Moyamoya disease: a review of histopathology, biochemistry, and genetics","volume":"30","author":"Weinberg","year":"2011","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2016.05.081_bib20","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1074\/jbc.M007518200","article-title":"Prevention of kidney ischemia\/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment","volume":"276","author":"Park","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2016.05.081_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2840-4-3","article-title":"Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction","volume":"4","author":"Chen","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.wneu.2016.05.081_bib22","doi-asserted-by":"crossref","first-page":"F938","DOI":"10.1152\/ajprenal.00706.2012","article-title":"Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model","volume":"304","author":"Wang","year":"2013","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.wneu.2016.05.081_bib23","first-page":"1357","article-title":"p38 mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells","volume":"13","author":"Hashimoto","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.wneu.2016.05.081_bib24","doi-asserted-by":"crossref","first-page":"L440","DOI":"10.1152\/ajplung.1999.277.3.L440","article-title":"Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors","volume":"277","author":"Morrell","year":"1999","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.wneu.2016.05.081_bib25","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.4049\/jimmunol.164.4.2151","article-title":"Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation","volume":"164","author":"Nick","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.wneu.2016.05.081_bib26","doi-asserted-by":"crossref","first-page":"H1351","DOI":"10.1152\/ajpheart.91526.2007","article-title":"Molecular and physiologic characterization of RV remodeling in a murine model of pulmonary stenosis","volume":"295","author":"Urashima","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.wneu.2016.05.081_bib27","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1161\/01.CIR.0000147610.41984.E8","article-title":"Upregulation of myocardial estrogen receptors in human aortic stenosis","volume":"110","author":"Nordmeyer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.wneu.2016.05.081_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/CIRCULATIONAHA.104.528802","article-title":"Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation","volume":"112","author":"\u00d6llinger","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.wneu.2016.05.081_bib29","doi-asserted-by":"crossref","first-page":"L895","DOI":"10.1152\/ajplung.2000.279.5.L895","article-title":"SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung","volume":"279","author":"Underwood","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.wneu.2016.05.081_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11010-014-2068-5","article-title":"Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK\/p38 MAPK pathways","volume":"393","author":"Cui","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.wneu.2016.05.081_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jvs.2011.12.038","article-title":"Transforming growth factor-\u03b2 increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways","volume":"56","author":"Suwanabol","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.wneu.2016.05.081_bib32","doi-asserted-by":"crossref","first-page":"e79657","DOI":"10.1371\/journal.pone.0079657","article-title":"Transforming growth factor \u03b2 inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation","volume":"8","author":"Martin-Garrido","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2016.05.081_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10753-015-0242-x","article-title":"Icariin attenuates high-cholesterol diet induced atherosclerosis in rats by inhibition of inflammatory response and p38 MAPK signaling pathway","volume":"39","author":"Hu","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.wneu.2016.05.081_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.20118","article-title":"Macrophages: an elusive yet emerging therapeutic target of atherosclerosis","volume":"28","author":"Tiwari","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.wneu.2016.05.081_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A\u00a0CD36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.wneu.2016.05.081_bib36","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.1101909","article-title":"Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis","volume":"306","author":"Ricci","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.wneu.2016.05.081_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1034\/j.1600-0463.2002.100604.x","article-title":"Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL","volume":"110","author":"Zhao","year":"2002","journal-title":"APMIS"},{"key":"10.1016\/j.wneu.2016.05.081_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2176\/nmc.52.333","article-title":"Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery","volume":"52","author":"Kim","year":"2012","journal-title":"Neurol Med Chir"},{"key":"10.1016\/j.wneu.2016.05.081_bib39","first-page":"12","article-title":"The pathophysiology of moyamoya disease: an update","volume":"18","author":"Bang","year":"2016","journal-title":"J\u00a0Stroke"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1878875016303552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1878875016303552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T04:14:02Z","timestamp":1568002442000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875016303552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"alternative-id":["S1878875016303552"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2016.05.081","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.wneu.2016.05.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}